On August 29, 2025 ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, reported that ALX Oncology leadership will participate in both the Cantor Global Healthcare Conference 2025 and H.C. Wainwright 27th Annual Global Investment Conference in New York (Press release, ALX Oncology, AUG 29, 2025, View Source [SID1234655580]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The details of the meetings are as follows:

Cantor Global Healthcare Conference

Format: Fireside Chat and One-on-one Meetings
Date: Wednesday, September 3, 2025
Location: New York, NY
Time of Fireside Chat Presentation: 9:45 AM ET
Webcast link: Available here

H.C. Wainwright 27th Annual Global Investment Conference

Format: One-on-one meetings
Date: Tuesday, September 9, 2025
Location: New York, NY
Webcast link: Pre-recorded fireside chat presentation available here

The webcasts of the Cantor and H.C. Wainwright fireside chats can be accessed by visiting the Investors section of ALX Oncology’s website at www.alxoncology.com under the Events section of the Events and Presentations tab. Replays of the webcasts will be archived for up to 90 days following the fireside chat dates.